Complete Guide to Depigmentation Therapy for Extensive Vitiligo
Table of Contents
What Is Depigmentation Therapy?
Depigmentation therapy is a dermatological treatment approach for extensive vitiligo in which the remaining normally pigmented skin is deliberately removed to create a uniform, consistent skin appearance that matches the existing white vitiligo patches. Rather than attempting to restore pigment (repigmentation), depigmentation therapy accepts the vitiligo and works to create visual uniformity.
The only FDA-approved agent for this purpose is monobenzone cream — specifically indicated for this use since 1952.
Repigmentation vs Depigmentation — The Decision
| Approach | Goal | Best For | Permanence | Success Rate |
|---|---|---|---|---|
| Repigmentation | Restore color to white patches | Limited vitiligo (<50%) | Variable | Partial in many cases |
| Depigmentation | Remove remaining pigment for uniform skin | Extensive vitiligo (>50%) | Permanent | High when correctly selected |
Most dermatological guidelines recommend attempting repigmentation therapies first. Depigmentation is typically considered when vitiligo is extensive and repigmentation has failed or is unlikely to succeed.
Who Is a Candidate for Depigmentation Therapy?
The following clinical criteria are generally used to identify appropriate candidates:
- Vitiligo extent: 50% or more of body surface area affected by vitiligo
- Treatment history: Failed repigmentation after 12+ months of appropriate therapy (NB-UVB, PUVA, topical steroids, tacrolimus)
- Psychological readiness: Full understanding that the result is permanent and irreversible
- Medical supervision: Commitment to ongoing dermatologist supervision throughout treatment
- Age: Adults or adolescents with specialist guidance; not routinely for children under 12
The Depigmentation Protocol — Step by Step
- Dermatologist assessment: Formal diagnosis of extensive vitiligo, documentation of extent, and assessment of suitability for depigmentation therapy
- Informed consent: Thorough discussion of permanence, side effects, sun sensitivity, and realistic expectations
- Start with 20%: Begin with monobenzone 20% cream applied twice daily to assess skin tolerance
- Tolerance assessment: Monitor for 4–8 weeks at 20% before considering progression to 40%
- Regular review: Monthly dermatologist appointments to assess progress and manage side effects
- Sun protection: SPF 50+ broad-spectrum sunscreen applied daily from first application — permanently after completion
- Treatment completion: Full depigmentation typically achieved at 9–12 months
What to Expect During Treatment
Phase 1 — Weeks 1–6: No visible change
Monobenzone is working at the cellular level during this phase. No visible skin changes occur. Some patients experience mild redness or itching — this is normal and manageable.
Phase 2 — Months 2–4: First results
Treated areas begin showing progressive lightening. This is usually the first "before and after" moment patients notice.
Phase 3 — Months 4–9: Main depigmentation phase
The most dramatic and visible results occur during this phase. Treated areas progressively lighten toward the natural white of existing vitiligo patches.
Phase 4 — Months 9–12: Completion
Complete, permanent depigmentation of treated areas is achieved. Clinical study PMC3533321 documented extremely satisfactory results with stability confirmed at 3-year follow-up.
Sun Protection After Depigmentation
This is non-negotiable. After monobenzone treatment, depigmented skin has permanently lost its natural UV protection (melanin). Without daily SPF 50+ sunscreen:
- Sunburn occurs extremely easily and severely
- Long-term photoaging risk increases significantly
- Risk of actinic damage in treated areas
SPF 50+ broad-spectrum sunscreen must be applied daily for life to all depigmented areas. In GCC countries with extreme UV intensity, SPF 70+ is advisable during summer months.
Depigmentation Therapy in the GCC Region
Vitiligo prevalence in GCC countries (Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain) is estimated at 2–3% — significantly above the global average of approximately 1%. This elevated prevalence means dermatologists across the Gulf region have substantial experience with vitiligo management including depigmentation therapy.
GulfDermaCare supplies Monozan® (monobenzone cream 20%, 40%, 60%) to patients across all GCC countries with 3–7 day delivery via UPS and FedEx.
Buy Monobenzone Cream — GulfDermaCare
Iranian Brand (Monozan by Behvazan Pharma) · From $12 · Ships to GCC in 3-7 days · WhatsApp order
Order on WhatsApp